AI Summary Viread (tenofovir disoproxil fumarate) is a nucleotide reverse transcriptase inhibitor and an established first-line oral antiviral for chronic hepatitis B, typically dosed at 300 mg once daily.
Medically reviewed.
Viread (tenofovir disoproxil fumarate) is a prescription antiviral medication used to treat chronic hepatitis B virus (HBV) infection in adults and certain pediatric patients. It belongs to a class of drugs called nucleotide reverse transcriptase inhibitors (NRTIs), which work by blocking viral replication and reducing the amount of hepatitis B virus in the body. Treatment decisions should always be individualized and guided by a healthcare professional.
This page covers Viread's role in chronic hepatitis B management — how it works, who may be eligible, benefits, side effects, and monitoring. You can also connect with a liver specialist near you for personalized guidance on whether Viread fits your care plan.
Liver Health AI Assistant
Ask Aimy
Aimy answers from LiverDirectory’s reviewed health information — helping patients make sense of liver-health terms, prepare for specialist visits, and explore what to look up next.
ABOUT VIREAD TREATMENT
Viread is a prescription medicine whose active ingredient is tenofovir disoproxil fumarate (TDF). It belongs to a class of medications called nucleotide reverse transcriptase inhibitors (NRTIs). Viread is used to treat chronic hepatitis B virus (HBV) infection in adults and certain pediatric patients.
Viread works by blocking the enzyme hepatitis B virus uses to copy its DNA, which lowers the amount of virus circulating in the blood. It is one of the established first-line oral therapies for chronic hepatitis B, alongside entecavir (Baraclude) and the newer tenofovir alafenamide (Vemlidy).
Viread is typically used long-term, alongside regular monitoring by your healthcare provider, such as Liver Function Tests (LFTs) and kidney function testing, to track viral suppression and treatment safety.
WHO VIREAD MAY BE SUITABLE FOR
Eligibility for Viread depends on your hepatitis B status, liver disease stage, and individual health needs. Your healthcare provider may prescribe Viread if you have chronic hepatitis B infection requiring long-term antiviral therapy, need treatment to reduce liver inflammation and prevent disease progression, or are at risk of developing cirrhosis or liver cancer due to HBV infection.
Antiviral treatment is generally considered for people with HBV DNA levels above 2,000 IU/ml and ALT levels above the upper limit of normal, along with at least moderate liver inflammation or fibrosis confirmed by biopsy or non-invasive testing. People with higher viral loads and liver enzyme levels may be started on treatment regardless of fibrosis stage.
Because every patient's hepatitis B status and liver condition is different, there is no one-size-fits-all answer to who should take Viread. Treatment decisions are individualized and should be made by a qualified healthcare professional after a full assessment of your liver condition and treatment goals.
ELIGIBILITY OVERVIEW
Viread may be considered for adults with the following conditions, risk factors, or treatment goals:
Before recommending Viread, healthcare providers evaluate several factors to determine whether it is an appropriate option, including:
HOW VIREAD CAN HELP YOUR LIVER
Viread inhibits the enzyme hepatitis B virus needs to replicate its DNA. By blocking this step, Viread reduces the amount of virus circulating in the bloodstream, known as the viral load.
As viral load falls, the liver inflammation driven by ongoing HBV replication tends to ease over time. This can help slow the progression of liver fibrosis (scarring) and reduce the long-term risk of cirrhosis and HBV-related complications, including liver cancer.
Viread is not used to cure hepatitis B — it suppresses the virus rather than eliminating it. Providers pair it with regular monitoring, including Liver Function Tests (LFTs), kidney function tests, and HBV viral load testing, to track response and safety over the course of treatment.
LIVER BENEFITS
Viread blocks the viral enzyme that hepatitis B virus (HBV) uses to copy its DNA. With fewer new copies being made, the amount of virus in the bloodstream, known as the viral load, goes down. Your healthcare provider tracks this with regular HBV viral load tests to see how well the medication is working for you.
Ongoing HBV replication keeps the immune system attacking infected liver cells, which causes inflammation. As viral replication slows, this inflammation tends to decrease. Liver function tests help your care team follow this change over time.
Long-term inflammation can lead to fibrosis, which is scarring of the liver, and eventually to cirrhosis. By keeping the virus suppressed over time, Viread helps slow this progression. Preventing cirrhosis is one of the main long-term goals of hepatitis B treatment, according to AASLD guidance.
Chronic hepatitis B can lead to serious complications, including advanced liver disease and liver cancer. Sustained viral suppression with Viread lowers the risk of these HBV-related complications. Viread does not cure hepatitis B, so these benefits depend on staying on treatment and keeping up with follow-up visits.
Viread works by suppressing hepatitis B viral replication, which reduces liver inflammation and slows disease progression. It should only be started and monitored under the guidance of a qualified healthcare professional.
TREATMENT PROCESS
Viread is supplied as an oral tablet. Take exactly as prescribed by your healthcare provider, and check with your pharmacist if you have any questions about your specific tablet strength.
The typical dose is 300 mg once daily. Dosage adjustments may be required in patients with kidney impairment — your healthcare provider determines the right dose for you.
Viread is a once-daily oral tablet. Take it with or without food, at the same time each day. Always use it exactly as your healthcare provider directs, and do not adjust your dose without medical guidance.
Viread is generally used as a long-term or indefinite antiviral therapy for chronic hepatitis B. Treatment continues as long as viral suppression is needed and the medication is well tolerated, under regular medical supervision.
Store Viread tablets at room temperature, away from moisture and heat.
Your healthcare provider will regularly monitor liver function tests, kidney function, and HBV viral load. Report any side effects or unusual symptoms to your healthcare provider.
BENEFITS AND SAFETY
Viread (tenofovir disoproxil fumarate) may support people with chronic hepatitis B by suppressing viral replication, which helps reduce liver inflammation and slow the progression toward cirrhosis. As an established, once-daily oral therapy, it offers effective long-term viral suppression for eligible patients. The extent of these benefits varies from person to person, depending on baseline viral load, liver condition, and how the body responds to therapy. Viread is not a cure for hepatitis B — it works best as part of a broader, personalized care plan that combines the medication with liver-protective lifestyle habits and ongoing monitoring, such as Liver Function Tests (LFTs), kidney function tests, and HBV viral load testing.
As with any medication, Viread may cause side effects, ranging from mild digestive symptoms to changes in kidney function. Your healthcare provider will monitor your kidney function and liver tests throughout treatment and assess whether Viread remains a suitable option for you.
BENEFITS
Viread inhibits HBV DNA replication and reduces the amount of virus circulating in the blood. This helps bring chronic hepatitis B infection under control. Viread is an established first-line oral therapy, and it is one of three preferred antiviral options in EASL and AASLD guidance, alongside entecavir and tenofovir alafenamide.
By lowering viral load, Viread helps reduce the liver inflammation that chronic hepatitis B causes. Less inflammation may help limit further liver injury over time. Your provider follows this progress with liver function tests during treatment.
Sustained viral suppression with Viread helps slow the progression of liver fibrosis and lowers the risk of advancing to cirrhosis. Preventing cirrhosis, liver cancer, and liver-related death are the main long-term goals of antiviral treatment. How much benefit you get depends on your viral load, your liver condition, and how your body responds.
Viread is a once-daily oral tablet that you can take with or without food, at the same time each day. This simple routine makes long-term treatment practical for people who need ongoing antiviral therapy. Regular monitoring, including kidney function checks, helps keep long-term use safe.
These effects are often mild and may improve over time. Your healthcare provider will discuss the potential benefits and risks before treatment and provide ongoing support, including kidney function monitoring, to ensure safe use.
SUPPORTING YOUR RESULTS
Viread works best when combined with healthy lifestyle habits such as avoiding alcohol, maintaining a balanced diet, managing weight, and following measures to protect liver health.
These habits can support how your liver responds to treatment and help reduce the overall risk of liver injury alongside viral suppression.
Areas that may support treatment:
COMMON QUESTIONS
No, Viread (tenofovir disoproxil fumarate) does not cure hepatitis B. It suppresses hepatitis B virus replication and lowers viral load, which helps reduce liver inflammation and slow the progression of fibrosis and cirrhosis, but the virus remains in the body. Most people need long-term or indefinite therapy to maintain viral suppression, and stopping treatment can allow the virus to become active again. Talk with your healthcare provider about realistic treatment goals and what stopping or continuing therapy would mean for your liver health.
Good candidates for Viread (tenofovir disoproxil fumarate) generally have chronic hepatitis B with HBV DNA levels above 2,000 IU/mL, elevated ALT, and at least moderate liver inflammation or fibrosis on biopsy or non-invasive testing. People with higher viral loads and liver enzyme levels may start treatment regardless of fibrosis stage. Kidney function is also assessed, since dosing may need adjustment. Because hepatitis B status and liver health vary widely between patients, there is no single answer that fits everyone. A healthcare professional should review your full history and test results before recommending Viread.
Most people take Viread (tenofovir disoproxil fumarate) as a long-term or indefinite therapy for chronic hepatitis B. Treatment continues for as long as viral suppression is needed and the medication remains well tolerated, under regular medical supervision. Stopping antiviral therapy without guidance can allow the hepatitis B virus to become active again and increase the risk of liver damage. Your healthcare provider will periodically reassess your viral load, liver function, and overall health to decide whether continuing, adjusting, or eventually stopping treatment is appropriate for you.
Viread (tenofovir disoproxil fumarate) commonly causes mild side effects such as nausea, diarrhea, headache, and fatigue, which often improve over time. It can also cause changes in kidney function, so your healthcare provider monitors kidney tests regularly throughout treatment. Most side effects are manageable, but you should report any new or worsening symptoms promptly. Your provider will weigh the benefits of viral suppression against these risks and may adjust your dose or monitoring schedule if needed. Always discuss any side effects you notice with a qualified healthcare professional.
While taking Viread (tenofovir disoproxil fumarate), your healthcare provider regularly checks liver function tests, kidney function, and HBV viral load to track how well the medication is controlling the virus. This monitoring also helps catch side effects early, particularly changes in kidney function, which is a known risk with this medication. Testing frequency depends on your individual health status and how you respond to treatment. Consistent follow-up appointments allow your provider to adjust your care plan as needed and confirm that Viread continues to be a safe, effective option for you.
Viread (tenofovir disoproxil fumarate) works best when combined with liver-friendly lifestyle habits rather than relying on medication alone. Avoiding alcohol, eating a balanced diet, managing your weight, and steering clear of substances that increase liver injury risk can all support how your liver responds to treatment. These habits do not replace antiviral therapy, but they may help reduce the overall burden on your liver alongside viral suppression. Ask your healthcare provider or a liver specialist for personalized guidance on diet and lifestyle changes that fit your situation.
Medical disclaimer: LiverDirectory provides educational information and a directory of providers. It does not provide medical advice, diagnosis, or treatment. Always consult a licensed physician regarding any medical condition.
